SEARCH

SEARCH BY CITATION

References

  • Alvarez-Larrán, A., Del Rio, J., Ramirez, C., Albo, C., Pena, F., Campos, A., Cid, J., Muncunill, J., Sastre, J.L., Sanz, C. & Pereira, A. (2004) Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sanguinis, 86, 246251.
  • Bianchi, V., Robles, R., Alberio, L., Furlan, M. & Lammle, B. (2002) Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood, 100, 710713.
  • Cardigan, R., Allford, S. & Williamson, L. (2002) Levels of von Willebrand factor-cleaving protease are normal in methylene blue-treated fresh-frozen plasma. British Journal of Haematology, 117, 253254.
  • Coppo, P., Bengoufa, D., Veyradier, A., Wolf, M., Bussel, A., Millot, G.A., Malot, S., Heshmati, F., Mira, J.P., Boulanger, E., Galicier, L., Durey-Dragon, M.A., Fremeaux-Bacchi, V., Ramakers, M., Pruna, A., Bordessoule, D., Gouilleux, V., Scrobohaci, M.L., Vernant, J.P., Moreau, D., Azoulay, E., Schlemmer, B., Guillevin, L. & Lassoued, K. (2004) Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore), 83, 233244.
  • Council of Europe (2007) Plasma, fresh frozen (FFP). In: Guide to the Preparation, Use and Quality Assurance of Blood (ed. by Council of Europe publishing), pp. 157161. Council of Europe Publishing, Strasbourg, France.
  • Freedman, B. (1987) Equipoise and the ethics of clinical research. New England Journal of Medicine, 317, 141145.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lammle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 15781584.
  • Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lammle, B. & Furlan, M. (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 13861389.
  • Haubelt, H., Blome, M., Kiessling, A.H., Isgro, F., Bach, J., Saggau, W. & Hellstern, P. (2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sanguinis, 82, 914.
  • Hellstern, P. (2004) Solvent/detergent-treated plasma: composition, efficacy, and safety. Current Opinion in Hematology, 11, 346350.
  • Henon, P. (1991) Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study. Presse Medicale, 20, 17611767.
  • Henschen-Edman, A.H. (1997) Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion. Cellular and Molecular Life Sciences, 53, 2933.
  • Horowitz, M.S. & Pehta, J.C. (1998) SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis, 74(Suppl. 1), 231235.
  • Inada, Y., Hessel, B. & Blomback, B. (1978) Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochimica et Biophysica Acta, 532, 161170.
  • Lambrecht, B., Mohr, H., Knuver-Hopf, J. & Schmitt, H. (1991) Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sanguinis, 60, 207213.
  • McCarthy, L.J., Danielson, C.F., Rothenberger, S.S., Parker, C., Weidner, J., Miraglia, C., Matus, D. & Waxman, D. (2000) Completely converting a blood service region to the use of safer plasma. Transfusion, 40, 12641267.
  • Mintz, P.D., Neff, A., MacKenzie, M., Goodnough, L.T., Hillyer, C., Kessler, C., McCrae, K., Menitove, J.E., Skikne, B.S., Damon, L., Lopez-Plaza, I., Rouault, C., Crookston, K.P., Benjamin, R.J., George, J., Lin, J.S., Corash, L. & Conlan, M.G. (2006) A randomized, controlled phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion, 46, 16931704.
  • Murphy, K., O’Brien, P. & O’Donnell, J. (2003) Acquired protein S deficiency in thrombotic thrombocytopenic purpura patients receiving solvent/detergent plasma exchange. British Journal of Haematology, 122, 518519.
  • Pereira, A. (2007) Viral safety measures of plasma for transfusion and applicability in Spain. Medicina clínica, 129, 458468.
  • Pereira, A., Mazzara, R., Monteagudo, J., Sanz, C., Puig, L., Martinez, A., Ordinas, A. & Castillo, R. (1995) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Annals of Hematology, 70, 319323.
  • Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C. & Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura Canadian Apheresis Study Group. New England Journal of Medicine, 325, 393397.
  • Rock, G., Porta, C. & Bobbio-Pallavicini, E. (2000) Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica, 85, 410419.
  • Rose, M. & Eldor, A. (1987) High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. American Journal of Medicine, 83, 437444.
  • De La Rubia, J., Arriaga, F., Linares, D., Larrea, L., Carpio, N., Marty, M.L. & Sanz, M.A. (2001) Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 114, 721723.
  • Shim, K., Anderson, P.J., Tuley, E.A., Wiswall, E. & Evan, S.J. (2008) Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood, 111, 651657.
  • Singh, Y., Sawyer, L.S., Pinkoski, L.S., Dupuis, K.W., Hsu, J.C., Lin, L. & Corash, L. (2006) Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion, 46, 11681177.
  • Solheim, B.G. & Seghatchian, J. (2006) Update on pathogen reduction technology for therapeutic plasma: an overview. Transfusion and Apheresis Science, 35, 8390.
  • Vesely, S.K., George, J.N., Lammle, B., Studt, J.D., Alberio, L., El-Harake, M.A. & Raskob, G.E. (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood, 102, 6068.
  • Veyradier, A., Obert, B., Houllier, A., Meyer, D. & Girma, J.P. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood, 98, 17651772.
  • Williamson, L.M., Cardigan, R. & Prowse, C.V. (2003) Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion, 43, 13221329.
  • Wollowitz, S. (2001) Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Seminars in Hematology, 38, 411.
  • Wyllie, B.F., Garg, A.X., Macnab, J., Rock, G.A. & Clark, W.F. (2006) Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. British Journal of Haematology, 132, 204209.
  • Yarranton, H., Lawrie, A.S., Purdy, G., Mackie, I.J. & Machin, S.J. (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfusion Medicine, 14, 3944.
  • Zeiler, T., Riess, H., Wittmann, G., Hintz, G., Zimmermann, R., Muller, C., Heuft, H.G. & Huhn, D. (1994) The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion, 34, 685689.